በኢሊኖይ ለግሊዎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለግሊዎማ የሚደረጉ 13 ጥናቶች በኢሊኖይ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በኢሊኖይ ውስጥ ያሉ ከተሞች
Official study text (English)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- University of Chicago Comprehensive Cancer Center, Chicago
- OSF Children's Hospital of Illinois, Peoria
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05099003Targeted Pediatric High-Grade Glioma Therapy
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Chicago, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05096481Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT04485559Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT05417594A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Northwestern Medicine, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT07464925MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ1 እስከ 26 · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁላይ 2026 · NCT06712875Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 2
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ29 ሜይ 2026 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Northwestern Memorial Hospital, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06810544rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 1
12 Months – 18 Years · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT04943848ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።